Science ❯ Biotechnology

Drug Development

Clinical Trials Clinical Research Oncology Cancer Research Therapeutics Regulatory Affairs Cancer Treatments Formulation Science Research and Development Targeted Therapies

Traws Pharma Raises $10 Million in PIPE With Up to $60 Million Tied to Trial Milestones

Future funding depends on U.K. challenge-trial milestones during an FDA hold.

RTW Buys $116 Million of Cogent Biosciences as Kynam Trims $48 Million Stake

Scientists Report New Trisulfide Metathesis Reaction That Rewrites S–S–S Bond Chemistry

Viking Therapeutics Pushes VK2735 Through Pivotal Trials as Next Enrollment Milestone Nears

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

AstraZeneca Pledges $15 Billion China Expansion Through 2030

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Insilico and Servier Strike Up to $888 Million AI-Oncology Partnership

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

Formycon, Zydus Seal Exclusive Deal for Keytruda Biosimilar in U.S. and Canada

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Olema Soars on Roche SERD Win, Then Slips on Planned Stock Offering

myTomorrows Raises $29 Million From Avego to Scale AI Platform for Pre-Approval Treatments

MIT's Timed Drug-Release Heart Patch Halves Damage in Rat Heart Attacks

Pfizer Wins Early U.S. Antitrust Clearance for Metsera Deal as Novo’s Higher Bid Pressures Timeline

FDA Accepts Replimune’s Resubmitted RP1 Melanoma Filing, Sets April 2026 Decision

Tubulis Raises €308 Million Series C to Accelerate Lead Cancer ADC

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH